Fundação Pio XII

Barretos 14784-400

1 studies enrolling now · 3 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, COVID-19, Hepatocellular Carcinoma, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
• Dapagliflozin in Respiratory Failure in Patients With COVID-19 — Completed